Kordasiewicz Holly B.
- SEC CIK
- 0002102721
In the past year, 3 open-market sale filings worth $4.81M and no purchases.
Current role at each company
- IONS Ionis Pharmaceuticals IncEVP, Chief Development Officeras of Jul 9, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $4.81M
- 3 filings
- Net
- −$4.81M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kordasiewicz Holly B. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 9, 2026 (view filing)6:07 PM ET | Jul 7 | 2 days | Kordasiewicz Holly B.EVP, Chief Development Officer | SSale | −362 | $84.30 | −$30.5K | −1.6%22.1K after | 10b5-1 |
| Jun 16, 2026 (view filing) | Jun 12 | 4 days | Kordasiewicz Holly B.EVP, Chief Development Officer | SSale | −60.8K | $73.40 | −$4.47M | −73.0%22.5K after | 2 lots10b5-1 |
| Jan 20, 2026 (view filing) | Jan 16 | 4 days | Kordasiewicz Holly B.EVP, Chief Development Officer | SSale | −4.14K | $75.66 | −$313.3K | −22.0%14.7K after |